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HPV and Cervical Cancer Control




Cervical cancer is a major cancer affecting 5.3 million women annually,
worldwide, and is responsible for about 2.7 million deaths per year. More than 85%
of the incident cases occur in developing countries. Cervical cancer is a totally
preventable cancer, if diagnosed in the precancer stages and treated effectively.
HPV vaccination has been introduced in many countries. Effective screening and
treatment programs are available in many health settings. Posttreatment histopath-
ological follow-up is done for 3–5 years. Cure from precancer condition and pre-
vention of invasive cervical cancer are thus attained. But the main hurdle in
achieving the above ambitious goal is the lacunae and deficiencies in conversion of
knowledge into practice by the women who are otherwise well informed about the
prevention of cervical cancer, as result of massive inputs in the field of health
education. Thus, the screening participation and compliance to precancer treatment
remain low. This barrier in translational knowledge should be overcome efficiently.
The author, from his vast experience in planning and implementing one of the
largest cervical cancer screening programs in India, has conceptualized “the
STAR model P6 principles of Raj” for successful conversion of “knowledge into
practice.”
Keywords: cervical cancer, screening, treatment, low participation,
translational knowledge to practice
1. Introduction
Cervical cancer is the fourth common cancer among women in the world, and
it accounts for about 530,000 new cases and 270,000 deaths annually, as reported
in 2012. About 85% of these cases occur in developing countries. It represents 12%
of incident cancers in women and 7.5% deaths due to cancer in women.
In a developing country like India, about 122,000 new cases of cervical cancer
and about 67,400 deaths due cervical cancer are reported, every year, as per data
of 2017. It is the second most frequent cancer among women of reproductive age
group.
India also has the highest age standardized incidence of cervical cancer in South
Asia at 22, compared to 19.2 in Bangladesh, 13 in Sri Lanka, and 2.8 in Iran [1, 2].
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2. The role of HPV
HPV is a necessary cause for cervical cancer [3].
More than 115 types of HPV are present and 18 are high-risk carcinogenic types
for cervical cancer. Other than this, HPV-16 is the most common high risk in
cervical cancer [4].
In cervical cancer cases, HPV prevalence was in the range of 87.8 to 96.67%,
in a study in India. In women without cervical cancer, HPV prevalence varied from
7.5 to 16.9%.
The worldwide prevalence of HPV infection, in normal woman, is between 9%
and 13%.
3. HPV infection worldwide
HPV is associated with 50,000 new cases of cervical cancer and 250,000
associated cervical cancer deaths, worldwide, each year [5]. It also causes vulvar,
vaginal, anal, and penile cancers and precancerous lesions of vulva/vagina, genital
warts, and respiratory papilomatosis [5, 6, 7]. HPV infections are asymptomatic,
and generally, individuals are not aware of being infected, thus facilitating the
spread easily and unknowingly [5].
At least 50% of men and women will acquire genital HPV infection during their
lifetime [8].
All sexually active women are infected with HPV at least once during their
lifetime, and the highest prevalence is seen soon after the onset of sexual activities
[9, 10].
A majority of episodes of type-specific HPV infection resolve spontaneously
within 2 years, but this may be followed by an infection with a new type [7].
HPV transmission exclusively occurs following skin-to-skin contact with an
infected partner. Sexual intercourse is not necessary, and the virus can be
transmitted through sexual foreplay [5].
HPV can only replicate in the stratified squamous epithelium. HPV infection
is the most common sexually transmitted diseases [11]. The major risk factor for
HPV infection is sexual behavior, including early age of onset of sexual activity,
multiple sexual partners, and coinfection with HIV [12].
Although the determinants of risk for persistent infection and progression to
invasive diseases are not fully understood, persistence appears to be related to HPV
type and concurrent infection with multiple virus types [12].
The prevalence and distribution of HPV types in the general population as well
as in cervical neoplasia vary with geographic region and by the grade of disease [13].
4. Screening for cervical cancer
Secondary prevention involves screening for precancerous lesions and treating
them. The three screening modalities are cytology, visual inspection, and HPV test.
5. Prevention of cervical cancer
HPV is necessary for the development of cervical cancer. Therefore, preventing
HPV infection can prevent cervical cancer. This can be achieved by complete
abstinence from sexual activity or by a vaccine [14].
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Primary prevention involves a risk reduction approach through behavioral
intervention for sexual and healthcare-seeking behavior or through mass immuni-
zation against high-risk HPV [15].
The objective of cervical screening/secondary prevention is to prevent invasive
cervical cancer from developing by detecting and treating women with CIN2/3
lesions, and the effectiveness is determined by reduction in incidence and mortality.
The critical components of a screening program are an acceptable good-quality
screening test, prompt diagnostic investigations, appropriate treatment, and
posttreatment follow-up [16].
There is a strong support from nonexperimental studies in developed countries
such as Denmark and Finland that the incidence and mortality of cervical cancer
can be reduced by screening [17].
Ensuring high levels of participation and sufficient healthcare infrastructure and
human resources are important for a screening program to succeed [18]. It is also
important for screening to be guided by equity considerations for those who are
more vulnerable or with lesser access to healthcare services because of social,
economic, or demographic factors [19].
Recent screening recommendations for specific age groups as per the American
Cancer Society (ACS) screening guidelines are as follows: [1, 2].
• At the age of 21 years: Screening is recommended.
• At the age of 21–29 years: Cytology (Pap smear) alone every 3 years.
• At the age of 30–65 years: Human papillomavirus virus (HPV) and cytology
contesting every 5 years or cytology alone every 3 years.
• At the age of >65 years: No screening recommended if adequate prior
screening has been negative and high risk is not present.
HPV Vaccines that aims to prevent cervical cancer are:
• A bivalent vaccine which protects against subtypes 16 and 18.
• A quadrivalent vaccine which protects against subtypes 16 and 18 plus
6 and 11.
• A 9-valent vaccine which protects against the same subtypes as the
quadrivalent plus subtypes 31, 33, 45, 52, and 58 (which cause about 15% of
cervical cancers).
• The HPV vaccine is ideally recommended to vaccinate boys and girls at age
11–12 years, but vaccination can begins at age 9.
6. The effect of HPV vaccination
1.Population-level impact and herd effects following the introduction of human
papillomavirus vaccination programs
From the abstract:We did a systematic review and meta-analysis of the population-
level impact of vaccinating girls and women against human papillomavirus on HPV
infections, anogenital wart diagnoses, and cervical intraepithelial neoplasia grade 2+
(CIN2+). Our results show compelling evidence of the substantial impact of HPV
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vaccination programs on HPV infections and CIN2+ among girls and women, and
on anogenital warts diagnoses among girls, women, boys, and men, programs with
multi-cohort vaccination and high vaccination coverage had a greater direct impact
and herd effects.
Ref: Population-level impact and herd effects following the introduction of human
papillomavirus vaccination programmes: updated systematic review and meta-analysis
Drolet M, Bénard É, Pérez N, Brisson M, on behalf of the HPV Vaccination Impact
Study Group. The Lancet. Open access
2.Human papillomavirus (HPV) vaccination significantly reduces the frequency
of genital HPV 16 and 18 infections and cervical intraepithelial neoplasia grade
2+ (CIN2+) in young women and shows signs of herd effects with a reduced
frequency of anogenital warts in both young women and men, a recent study
showed.
As cited in infectious diseases.
9/16/2019 HPV vaccination programmes reduce HPV infection, precancerous




7. KAP studies reveal the presence of adequate knowledge but
inadequate “practice “in the community
7.1 Recent study in India
Results: We observed that despite good knowledge and perception, less than 10
percent of workers have undergone screening. Significant association was seen
between the level of knowledge and practice of screening.
Conclusion: It is of utmost importance narrowing of existing gap between the
perception and practice of cervical cancer.
Screening should be initiated through introducing more educational programs
for workers and encouraging them to participate.
The study cited is from: Khanna D, Khargekar N, Budukh A. Knowledge, atti-
tude, and practice about cervical cancer and its screening among community
healthcare workers of Varanasi district, Uttar Pradesh, India. J Family Med Prim
Care 2019;8:1715–9.
8. How to translate “knowledge” in to “practice”
Author’s experiences in a cervical cancer screening program of the IARC/WHO,
In India.
8.1 The development of the STAR model P-6 principles of raj©
The author, having been successful in planning and implementing, such a
model, and achieving a reduction in the incidence rate of cervical cancer by 25% and
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mortality due to cervical cancer by 35%, in a period of 7 years—2000 to 2007,
strongly recommends the STAR model P-6 principles of Raj©.
He has served as the principal investigator for the first 3 years, and the project
was done at the Christian Fellowship Community Health Centre Society,
Ambilikkai, Dindigul district, Tamil Nadu, India, and was in technical collaboration
with the International Agency for Research on Cancer (IARC), WHO.
9. Background
Proof of concept (POC)—The Lancet Publication 2007, the author’s paper.
Quote:
Effect of visual screening on cervical cancer incidence and mortality in Tamil
Nadu, India: a cluster-randomized trial.
Lancet 2007; 370(9585):398-406.
Rengaswamy Sankaranarayanan, Pulikkottil Okkuru Esmy, Rajamanickam
Rajkumar, et al.
10. Summary
Cervical cancer is the most common cancer among women in developing coun-
tries. We assessed the effect of screening using visual inspection with 4% acetic acid
(VIA) on cervical cancer incidence and mortality in a cluster-randomized con-
trolled trial in India.
11. Methods
Of the 114 study clusters in Dindigul district, India, 57 were randomized to one
round of VIA by trained nurses and 57 to a control group. Healthy women aged 30–
59 years were eligible for the study. Screen-positive women had colposcopy,
directed biopsies, and, where appropriate, cryotherapy by nurses during the
screening visit. Those with larger precancerous lesions or invasive cancers were
referred for appropriate investigations and treatment.
Cervical cancer incidence and mortality in the study groups were analyzed and
compared using Cox regression taking the cluster design into account, and analysis
was by intention to treat. The primary outcome measures were cervical cancer
incidence and mortality.
12. Results
Of the 49,311 eligible women in the intervention group, 31,343 (636%) were
screened during 2000–2003; 30,958 control women received the standard care. Of
the 3088 (99%) screened positive, 3052 had colposcopy and 2539 directed biopsy.
Of the 1874 women with precancerous lesions in the intervention group, 72%
received treatment. In the intervention group, 274,430 person years, 167 cervical
cancer cases, and 83 cervical cancer deaths were accrued compared with 178,781
person years, 158 cases, and 92 deaths and in the control group during 2000–2006
(incidence hazard ratio 075 [95% CI 055–095] and mortality hazard ratio 065
[047–089]).
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13. Interpretation
HPV vaccination and organized screening, in the presence of good training
and sustained quality assurance, are effective methods, for HPV and cervical
cancer prevention and control, in developing countries. New and innovative
models and effective strategies for health education need to be developed to
strengthen the “knowledge translation to action” component of the healthcare
delivery systems,
14. Health education: for HPV prevention and control
The STAR model P-6 principles of Raj©.
Health education, with special strategies to effect the “practice” in a suc-
cessful way, is the key, for prevention and control of HPV infections and
cervical cancer.
Proposed strategy:
Knowledge transformation through p6 pathway©
6
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15. The P6 principles
15.1 P1. Projection
15.1.1 Health education process
It is very important that all the health-related programs have a very strong
foundation with the component of health education, may it be to an individual,
family, or a community. The healthcare planners, administrators, and providers are
responsible for developing various methods, tools, strategies for the delivery of
effective health education. In some health programs, it is called information, edu-
cation, communication strategies. In this process, an idea, theme, concept, facts and
figures, health topics, health problems, and solutions are being projected.
15.1.2 Negative projections
These are usually warning projections. For example, tobacco products have scary
pictures of lung cancers, and head and neck cancers are printed on the packs. These
are meant to arouse a sense of fear and discourage the consumer from using it. But,
the feelings and its effect are temporary, resulting in continued habits. The con-
sumers may not like the “advertisement” but likes the advertised. Such “dramatic
“projections,” are not ideal for health education on sensitive issues like HPV.
Negative projections
15.1.3 Positive/pleasant projections
The messages to be delivered are projected in a positive, attractive way. This is
also a temporary appeal to their emotions. Without in-depth analysis, the con-
sumers patronize the messages but on the long run has no permanent implications.
The advertisements on the health drinks are such “positive and pleasant projec-
tions.” Such projections are not suitable for behavior change targeted HP health
education messages.
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Positive/pleasant projections
15.1.4 Permanent behavior change projections
These projections are prosperous, progressive, peaceful, and productive. They
imply that acceptance and adoption of the advertised message would lead to happy,
healthy future. Health education messages in family planning are designed and
developed like this. The example of one such advertisement shows a happy family
with two children joyfully bonded with love and affection.
The consumer is highly impressed, inspired, and convinced to consider adopting
family planning methods to have a small and self-sufficient family, in the future.
Likewise, in HPV-related health education messages, we should have permanent
behavior change projections like HPV vaccination, menstrual hygiene, sexual
hygiene, and regular periodic screening for cervix cancer, and these are the ideal
and apt projections.
Permanent behavior change projections






It is the formation of an idea or concept, depending upon the effects of various
stimuli received, to perform an act.
15.2.1 Perception process: the i5
Ignite Imagine Interest Inspire Implement
Ignition: “Don’t let cervical cancer stop you.”
Imagine: End cervical cancer.
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Interest: Easy two ways—“get vaccinated, get screened.”
Inspire: Peer group inspires.
Implement: Get vaccination/screening done.
15.3 P3. Promotion
15.3.1 Health promotion model
Successful and productive past experiences; beliefs getting renewed and ratio-
nalized; benefits accrued both temporarily and permanently; breaking of barriers
by several inputs and interventions; positive influence from family, friends, peers,
and society; esthetic situations favoring and promoting empowerment by self-
efficacy, all these factors serve as a diving plank, providing strong and sustained





This is a continuous process where each step is evaluated and replanned for
better implementation in the next step.
Therefore in every performance, there is a betterment of the next practice. This
is depicted in the performance enhancement cycle (PEC).
Performance enhancement cycle (PEC)
15.5 P5. Perseverance
Perseverance is constant, continued efforts and attempts, amidst of many
difficulties, until the desired goal is achieved. This is an important process in
healthcare delivery, where the health providers make sustained efforts to
convince the healthcare recipients to adopt the desired behavior in order to
achieve the appropriate and relevant goals. The act of “perseverance” largely
depends upon the level and depth of perception of the health problem; the
support given by family, peers, and society; and the evaluation of the eventual
results and benefits. In the community, we can see the example of a pregnant
woman in a family, where everyone realizes the preciousness of pregnancy and
has in-depth perception and the family, relatives, community, and society offer
all the support needed for the pregnant woman, amidst of many problems and
difficulties, for a long period of maternity, and these acts of perseverance
eventually result in the successful outcome of a safe delivery, healthy mother,
and a healthy child.
In HPV control measures, perseverance is needed for effecting behavioral
changes like menstrual hygiene, sexual health, adoption of HPV vaccine and most
importantly screening and treatment for precancer status and regular follow-up as
needed. Hence,“perseverance” in health education, healthcare delivery, and follow-
up is a very important component of the goal-oriented system.
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Perseverance in care during pregnancy for safe delivery
The common example of a pregnant woman and her family, community, and
society, being offered all support and help for a successful outcome, amidst many
difficulties, by acts of perseverance.
15.6 P6. Pursuit
The yacht in pursuit of destination amidst problems
In pursuit of excellence is a requirement by one and all for success and achieve-
ments. In the field of healthcare planning, delivery, and implementation, one is in
pursuit of excellence in technologies, techniques, strategies, skills, and scientific—
social achievements.
Goals, objectives, and indicators to reach are already fixed, defined, and
targeted, in a well-planned health program. The health providers are in “pursuit” of
attaining these goals. There would be many difficulties, obstacles, shortcomings,
and hurdles in the entire process. But, the goal is clear, and all efforts are made to
12
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overcome these, and the aim is ultimately achieved. The yacht travel which over-
comes all difficulties like the sun, rain, storm, and many others, to reach its desti-
nation safely, and it’s a symbolism of “pursuit.”
In the HPV control programs, many such draw backs are seen. For example,
illiteracy, ignorance, and poverty, prevent the usage of sanitary napkins. This is
overcome by health education and mobilization of resources. The HPV vaccine has
obstacles like differing policies, cost of the vaccine, lack of infrastructure to reach
the vaccine to the community, and illiteracy and ignorance among the target
groups. Screening programs suffer from problems like ignorant community; lack of
infrastructure; deficient manpower; nonavailability of techniques, technology, and
technicians; and inadequate, inefficient systems in place. Yet, these can be over-
come by appropriate and adequate inputs, during the process of pursuit towards the
goals by the health planners.
The health programs in the developing world do experience this act of pursuit to
achieve goals, and already the results have been seen in reducing the incidence of
HPV infections and cervical cancer, especially in the low and limited resource
settings of many countries.
16. Raj’s cancer control clock
A complimentary model
The Keys for the Cancer Control Clock’s 12 hours [20]:
1.Area—define a geographic area for your study/services
2.Enumerate—the resident population, document the sociodemographic data
3.Inference—prevalence of HPV-related diseases—establish registries
4.Education—about prevention at individual, family, and community levels
5.Invitation—to attend awareness programs, screening, and vaccination
6.Counseling—the participants about possible outcomes and solutions
7.Screening—acceptable, available, accessible, affordable, answerable,
achievable—the A-6 model for screening and vaccination programs
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8.Patterns—of diseases detected in screening—disclosure of results—
individualized, ensure confidentiality and offer solution for health problems
9.Confirmation—diagnosis—at screening and follow-up stages
10.Treatment—of the HPV infections and related diseases, precancer lesions,
and ensure the availability of posttreatment services
11.Follow-up—by confirmation of disease free status, counseling, and referrals
to the government/private health systems
12.Monitoring, evaluation, replan—effectiveness of interventions, health
economics,and advocating prevention policies
17. Conclusion
The problem of high incidence of HPV infections and cervical cancer, all over
the world, especially in developing countries is of great concern and warrants
immediate control measures. Many programs have been planned and implemented
and they all show promising outcomes. The HPV vaccine uptake has increased due
to various inputs in developing countries. The increased vaccine coverage has
shown reduced incidence of cervical precancers in longitudinal studies. The screen-
ing programs for cervical cancer have resulted in reduction in the incidence rate of
cervical cancer and mortality due to cervical cancer.
18. The STAR model P-6 principles of raj©
This is a time-tested concept of the author, which was found to be very success-
ful in the proof of concept project quoted earlier. Hence, for effective implementa-
tion of HPV and cervical cancer screening programs, especially in the phase of
translating knowledge into practice, the above model is recommended, for the
benefit of health programs in developing countries.
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